Top Markets
#1 BOOK OF MEME BOOK OF MEME +29.78%
#2 Geodnet Geodnet +26.04%
#3 The Black Bull The Black Bull +25.24%
#4 XPIN Network XPIN Network +23.44%
#5 EXOD EXOD +22.08%
#6 Ore Ore +21.41%
#7 Verus Coin Verus Coin +20.44%
#8 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +20.08%
#9 Neiro Neiro +19.97%
#10 Bitcoin Cash Bitcoin Cash +19.67%
Coin of the day
BOOK OF MEME BOOK OF MEME
設定
言語
日本
通貨
USD
テーマ
Apollomics, Inc. Apollomics, Inc.

Apollomics, Inc.

APLM
株式のランク #25241
Apollomics, Inc., a biotechnology enterprise established in 2015 and... Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements. Its therapeutic pipeline features APL-101 (Vebreltinib), a potent and selective c-Met inhibitor being developed for non-small cell lung cancer and other advanced malignancies. Also in development is APL-102, an orally administered, small molecule multiple tyrosine kinase inhibitor intended for liver, breast, and esophageal cancers. Furthermore, APL-122 is an investigational tumor inhibitor candidate focused on treating cancers within the brain. The organization was formerly known as CBT Pharmaceuticals, Inc. before adopting the name Apollomics, Inc. in January 2019.
株価
$23.57
最終同期: 2026-08-20
時価総額
$51.76M
変化（1日）
-0.08%
変化（1年）
289.59%
国
US
取引 Apollomics, Inc. (APLM)

カテゴリー

Healthcare
Apollomics, Inc.（APLM）の収益
Aug 2026 時点の収益 TTM: 0
Apollomics, Inc. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Apollomics, Inc. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US